Cipla collaborates with Hetero to launch its second biosimilar drug 'Darbepoetin alfa' ~Patients with chronic kidney disease and anaemia set to gain~ India, Mumbai, 19th June 2014: Cipla, a global ...

Cipla Limited has announced that it has entered into a 60:40 joint venture agreement with Kemwell Biopharma Private Limited ...

Mumbai, India-based Cipla Inc. pharmaceuticals will establish a U.S. headquarters at Independence Place in Warren.Mumbai, India-based Cipla Inc. pharmaceuticals will establish a U.S. headquarters at ...

India, Mumbai, 7th July 2014: Cipla Limited, a global healthcare company, today announced in collaboration with the UK Government, its intention to make investments of up to £100 million in its UK ...

In March 2025, among the top-20 pharma companies as per Motilal Oswal Financial Services, JB Chemicals & Pharmaceutical marked a growth of 17.1% YoY, while Cipla Ltd saw sales grow 16.3% YoY. Ipca ...

Pharma Stocks: Shares of pharmaceutical companies are in action today (April 3) after the Trump administration exempted pharmaceuticals from reciprocal tariffs. The Nifty Pharma was the top sectoral ...

For a company that turns 90 this year, Cipla is making a concerted attempt to sound less like an institution and more like a brand still in the making. “I would say it is a 90-year-old startup,” Achin ...

It was another session of selloff at Dalal Street as Indian markets continued to bleed on Wednesday on the back rising inflation, relentless FIIs selling and weak Q2 performance by India Inc. Indian ...

Cipla shares are in demand on Dalal Street amid market buzz that it is in talks with Eli Lilly for the Semaglutide drug. Catch the latest market updates here. Cipla shares buzzed in trade on Monday.

After a challenging year marked by tariff concerns, pricing pressures, and broader macro headwinds, the drug and biotech sector has shown signs of recovery in October. Historically, the month has seen ...

The over-the-counter arm of Cipla Ltd plans to leverage its blockbuster brands and strong tier-II to tier-VI presence to ...